Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
I-Mab Biopharma US Limited
University Hospital, Akershus
AstraZeneca
UNICANCER
NuCana plc
Memorial Sloan Kettering Cancer Center
Ruijin Hospital
Asan Medical Center
Hoosier Cancer Research Network
H. Lee Moffitt Cancer Center and Research Institute
Ludwig-Maximilians - University of Munich
Federation Francophone de Cancerologie Digestive
Groupe Oncologie Radiotherapie Tete et Cou
Translational Oncology Research International
Grupo Espanol Multidisciplinario del Cancer Digestivo
AIO-Studien-gGmbH
UNICANCER
UNICANCER
University of Florida
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Daiichi Sankyo
M.D. Anderson Cancer Center
Amgen
Galectin Therapeutics Inc.
European Organisation for Research and Treatment of Cancer - EORTC
City of Hope Medical Center
H. Lee Moffitt Cancer Center and Research Institute
Alliance for Clinical Trials in Oncology
Washington University School of Medicine
Georgetown University
Huashan Hospital
Memorial Sloan Kettering Cancer Center
Vanderbilt University
Royal Marsden NHS Foundation Trust
Bayer
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute, France
European Organisation for Research and Treatment of Cancer - EORTC
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AstraZeneca
National Cancer Institute (NCI)
Pfizer
National Institutes of Health Clinical Center (CC)
Southwestern Regional Medical Center